Upvote0Points0PointsUpvotes:0Downvotes:0Total Votes:0DownvoteNitya VashishthaDeals2 years agoKirkland Advises Bernhard Capital and its DOE and NNSA Platform on Purchase of SMSIRead MoreFacebookX.comPinterestLinkedinEmail868170
Upvote0Points0PointsUpvotes:0Downvotes:0Total Votes:0DownvoteNitya VashishthaDeals2 years agoKirkland Advises Wind Point Partners on Sale of Handgards To Wynnchurch CapitalRead MoreFacebookX.comPinterestLinkedinEmail878170
Upvote0Points0PointsUpvotes:0Downvotes:0Total Votes:0DownvoteNitya VashishthaDeals2 years agoKirkland Advises Benchmark on Securing $150 Million Revolving Credit FacilityRead MoreFacebookX.comPinterestLinkedinEmail871170
Upvote0Points0PointsUpvotes:0Downvotes:0Total Votes:0DownvoteNitya VashishthaDeals2 years agoLatham & Watkins Advises Apollo on Concord’s Proposed US$1.4 Billion Acquisition of HipgnosisRead MoreFacebookX.comPinterestLinkedinEmail882170
Upvote0Points0PointsUpvotes:0Downvotes:0Total Votes:0DownvoteNitya VashishthaDeals2 years agoLatham Advises Osaka Gas, Sumitomo Corporation and JOIN on Investment in AG&P LNG MarketingRead MoreFacebookX.comPinterestLinkedinEmail881170
Upvote0Points0PointsUpvotes:0Downvotes:0Total Votes:0DownvoteNitya VashishthaDeals2 years agoLatham Advises Quadriga Capital on Sale of Kinetics GroupRead MoreFacebookX.comPinterestLinkedinEmail871170
Upvote0Points0PointsUpvotes:0Downvotes:0Total Votes:0DownvoteNitya VashishthaDeals2 years agoLatham & Watkins Advises on Johnson Controls’ US$700 Million Senior Notes OfferingRead MoreFacebookX.comPinterestLinkedinEmail876170
Upvote0Points0PointsUpvotes:0Downvotes:0Total Votes:0DownvoteNitya VashishthaDeals2 years agoLatham & Watkins Represents UL Solutions Inc. in Upsized US$1.08 Billion IPORead MoreFacebookX.comPinterestLinkedinEmail878170
Upvote0Points0PointsUpvotes:0Downvotes:0Total Votes:0DownvoteNitya VashishthaDeals2 years agoLatham Advises DBAG Funds on Sale of Shares in SolvaresRead MoreFacebookX.comPinterestLinkedinEmail884170
Upvote0Points0PointsUpvotes:0Downvotes:0Total Votes:0DownvoteNitya VashishthaDeals2 years agoClifford Chance advises SciClone Pharmaceuticals on proposed HK$8.79 billion privatisation by GL CapitalRead MoreFacebookX.comPinterestLinkedinEmail887170
